Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.
about
How healthy is community-dwelling elderly population? Results from Southern Italy.Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients.Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trialGeriatric syndromes are potential determinants of the medication adherence status in prevalent dialysis patients.The support of medication reviews in hospitalised patients using a clinical decision support system.The influence of frailty syndrome on medication adherence among elderly patients with hypertension.Potentially inappropriate medications use in community-based aged patients: a cross-sectional study using 2012 Beers criteriaPharmacist's Comprehensive Geriatric Assessment: Introduction and Evaluation at Elderly Patient AdmissionAn evaluation of medication appropriateness and frailty among residents of aged care homes in Malaysia: A cross-sectional study.Sarcopenia and frailty in older patients with diabetes mellitus.Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population.Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France.Pre-Frailty, Frailty, and Multimorbidity: Prevalences and Associated Characteristics from Two French National Surveys.The development of an automated ward independent delirium risk prediction model.Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community.What is polypharmacy? A systematic review of definitions.Proceedings of the Canadian Frailty Network Summit: Medication Optimization for Frail Older Canadians, Toronto, Monday April 24, 2017.Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II.Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder Aged ≥75 Years: Analysis of a Japanese Post-Marketing Study.The relationship between Frailty and Polypharmacy in older people: a Systematic Review.The composition of polypharmacy: A register-based study of Swedes aged 75 years and older.Trends in polypharmacy over 12 years and changes in its social gradients in South Korea
P2860
Q36738492-5A7171F2-1B25-4AD5-92A3-BBD125D66DE0Q36805116-8D139C7C-D766-44D0-A35A-6C5DDDC2A072Q37007416-02242351-91CF-426B-8B0D-A98A80ABAA43Q37015932-35DEBAC8-3DBA-46EC-A152-F907391B2506Q37037498-6313DDFF-729E-4520-AF7C-7FB96BF12D5BQ37496481-B11B943B-CAE9-43D5-BBE9-43D181D36BA7Q37573115-300F79F3-6CBB-45B9-A61E-30803D123B50Q37675258-B8F8C1F9-FA32-40E6-86B8-1F0D06E1EDBAQ38600217-593E2B98-44C0-4AB1-A920-A261E0242AB3Q38707986-BD99D9FB-D25A-4195-8EDB-551938B28A5FQ38732016-A2522AA5-96C7-4ECF-8438-0FC2A6803CAFQ38732283-6565F733-63F5-4B50-A1A9-4FC70DB559E4Q38766079-BBCF7DB5-605F-441B-B1FC-9E6239EC9C88Q39017613-F82D2A02-7B8B-4E0C-8518-C59DFC208493Q39317873-B7DD7F86-C3CD-4F3E-A7E5-25E6A1BAA851Q39767737-B208DBB9-3A8B-4637-8546-3BE735166655Q40404771-BEFAA5CF-9DF9-4715-8A9F-AE1CC253D1CBQ42374534-6B1708E5-C24B-4326-BAEF-BEAA265F771AQ47103437-0AF66A85-C613-410A-A237-3F20A8A76943Q47770687-CB02917F-F6D0-478D-BA84-6AF5BFF90FA9Q47993403-4CF2F908-15BD-45D9-BF93-A40544016557Q51735324-9D3E72A2-8BE4-48A3-BF1D-30CD49E39B4FQ51758434-1A3C966F-C680-4C8E-94E4-DDBEA998450BQ57210601-A3B5AE73-A812-4421-AE2F-5AB14D524A78
P2860
Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Polypharmacy and frailty: prev ...... nch sample of 2350 old people.
@en
type
label
Polypharmacy and frailty: prev ...... nch sample of 2350 old people.
@en
prefLabel
Polypharmacy and frailty: prev ...... nch sample of 2350 old people.
@en
P2093
P2860
P356
P1476
Polypharmacy and frailty: prev ...... nch sample of 2350 old people.
@en
P2093
Jean-Jacques Arvieu
Joël Ankri
Juliette Pinot
P2860
P304
P356
10.1002/PDS.3772
P577
2015-04-08T00:00:00Z